E2F7 & E2F8 in the control of transcription and cellular proliferation
E2F7 & E2F8 in the control of transcription and cellular proliferation
批准号:
8204520
负责人:
GUSTAVO Walter LEONE
金额:
$30.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-10 至 2012-11-30
关键词:
Admission activityAffinity ChromatographyAnimalsApoptosisApplications GrantsBindingBiochemicalBiologicalCell CycleCell Cycle RegulationCell ProliferationChIP-on-chipCommitComplexCritiquesDataData CollectionDevelopmentEventFamilyFamily memberFutureGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionGoalsHomoIndividualKnock-outLaboratoriesLightMeasuresMediatingMindMolecularMultiprotein ComplexesMusOncogenicPatternPhosphotransferasesPlayPositioning AttributePrincipal InvestigatorProteinsPublished CommentReagentRecruitment ActivityResearchRoleSignal PathwaySorting - Cell MovementStructureSystemTechnologyTestingTissuesTranscription Repressor/CorepressorTumor Suppressor ProteinsWheatWorkarmcombinatorialfallsinterestknowledge basememberoverexpressionprogramspromotertooltranscription factor
中文摘要
转录因子E2F家族被认为在控制细胞内
扩散。这些因子由不同的基因编码,既有肿瘤抑制作用,又有致癌作用。
功能(1-2)。我们实验室确认E2F7和E2F8是该转录因子的最后两个成员
家庭(5,6)。本提案中提供的初步数据突出了这两个项目的几个独特之处
E2F将它们放在自己的子类中。这些显著特征包括它们形成的能力
同源二聚体和异源二聚体,与一大批转录共抑制因子相关联,以沉默
基因表达,并阻断细胞增殖。虽然它们缺乏典型的RB结合结构域,但E2F7可以
特异性地与RB相关蛋白相互作用,从而可以将E2F8招募到含有RB的复合体中。作为一名
结果:E2F网络中的E2F7/8臂仍受细胞周期依赖性激酶(CDK)的控制
信号通路。E2F7和E2F8具有相同的细胞周期依赖模式和组织-
特定的表达,加上它们同源和异源二聚体的能力,增加了它们
可能在动物身上既有独特的功能,又有共同的功能。实验室的多方面努力取得了成果
关键技术发展,包括纯化E2F7/8相关蛋白的亲和纯化策略,
启动子阵列技术用于识别靶基因,基因打靶方法用于干扰E2F7和
小鼠的E2F8。这些进展使我们的研究小组处于有利地位,能够取得重大进展
对E2F家族的这一重要分支是如何控制细胞的机械性理解
细胞周期和细胞增殖。这一提议的首要假设是E2F7和E2F8的功能是
转录抑制因子,以负向控制细胞增殖。利用生化的三个具体目标,
生物物理学、全球基因阵列和遗传学方法将直接检验这一假设:具体目标1。
鉴定和鉴定E2F7和E2F8相关的大分子蛋白质复合体。具体目标2.
鉴定E2F7和E2F8转录靶点。明确E2F7和E2F7的发病机制
E2F8在转录调控中的作用。这项工作将阐明个体和组合
这两位高度相关的家庭成员对全面了解E2F的贡献
转录活性。
项目说明第6页
英文摘要
The E2F family of transcription factors is believed to play a critical role in the control of cellular
proliferation. These factors are encoded by distinct genes and have both tumor suppressor and oncogenic
functions (1-2). Our laboratory identified E2F7 and E2F8 as the final two members of this transcription factor
family (5, 6). The preliminary data presented in this proposal highlight several unique features of these two
E2Fs that place them in a subclass of their own. These salient features include their ability to form
homodimers and heterodimers, to associate with a large cadre of transcriptional co-repressors, to silence
gene expression, and to block cellular proliferation. While they lack a typical Rb-binding domain, E2F7 can
specifically interact with Rb related proteins and can thus recruit E2F8 to Rb-containing complexes. As a
result, the E2F7/8 arm of the E2F network remains under the control of the cycling dependent kinase (CDK)
signaling pathway. The fact that E2F7 and E2F8 have an identical pattern of cell cycle dependent and tissue-
specific expression, together with their ability to homo- and hetero-dimerize, raises the possibility that they
may have both unique and shared functions in the animal. A multi-faceted effort in the laboratory has yielded
key technical developments, including an affinity purification strategy to purify E2F7/8-associated proteins,
promoter-array technologies to identify target genes, and gene targeting approaches to disrupt E2F7 and
E2F8 in mice. These advances place our research group in a strong position to make significant advances
towards a mechanistic understanding of how this important arm of the E2F family of factors controls the cell
cycle and cell proliferation. The overarching hypothesis of this proposal is that E2F7 and E2F8 function as
transcriptional repressors to negatively control cellular proliferation. Three specific aims utilizing biochemical,
biophysical, global gene array, and genetic approaches will directly test this hypothesis: Specific Aim 1. To
identify and characterize E2F7- and E2F8-associated macromolecular protein complexes. Specific Aim 2.
To identify E2F7 and E2F8 transcriptional targets. Specific Aim 3. To determine the mechanism of E2F7 and
E2F8 action in the control of transcription. This work will elucida the individual and combinatorial
contributions made by these two highly related family members towards the overall understanding of E2F
transcriptional activity.
Project Description Page 6
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma
-
批准号:9457804
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2017
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10589917
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Developmental Funds
-
批准号:10377477
-
项目类别:
-
资助金额:$58.11万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10377478
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Developmental Funds
-
批准号:10589916
-
项目类别:
-
资助金额:$58.11万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:9248275
-
项目类别:
-
资助金额:$209.3万
-
财政年份:2009
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7389747
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)
-
批准号:8698044
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7539216
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7749926
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F7 & E2F8 in the control of transcription and cellular proliferation
-
批准号:7995215
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2007
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7069571
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:9091438
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:6858634
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:6757647
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7232278
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:8678858
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Role of Rb and E2Fs in Regulating Stromal/Epithelial
-
批准号:6995150
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
E2F3 and embryonic development
-
批准号:7410004
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
Suppression of Mammary Tumorigenesis by Stromal p53
-
批准号:8246042
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2004
-
负责人:GUSTAVO Walter LEONE
-
依托单位:
海外基金